Active Pharmaceutical Ingredients
High‑quality APIs backed by scientific expertise
As part of our B2B offering, Zentiva provides access to a portfolio of active pharmaceutical ingredients developed and manufactured to stringent quality and regulatory standards.
Explore our active ingredients portfolio
| Molecule | Status | ATC Group |
|---|---|---|
| AGOMELATINE / AGOMELATINE COCRYSTAL | - | - |
| APIXABAN | - | - |
| ARTICAINE HCL | ASMF available | - |
| ELVITEGRAVIR | - | - |
| GLIBENCLAMIDE | ASMF available | - |
| IVACAFTOR | - | - |
| LERCANIDIPINE | - | - |
| PENTOXIFYLLINE | ASMF available | - |
| PERINDOPRIL ARGININE | - | - |
| PIRETANIDE | - | - |
| RAMIPRIL | - | - |
| RILMENIDINE DIHYDROGENPHOSPHATE | - | - |
| RIVAROXABAN | - | - |
| S-AMLODIPINE | - | - |
| S-IBUPROFEN | - | - |
| SACUBITRIL SODIUM | - | - |
| TAMSULOSIN HYDROCHLORIDE | - | - |
| TENOFOVIR ALAFENAMIDE | - | - |
| TEZACAFTOR | - | - |
| VALSARTAN SODIUM | - | - |
| VORTIOXETINE HYDROBROMIDE | - | - |
DISCLAIMER:
Any disposal with the product, including but not limited to the development, sale and offer for sale of products and related processes identified within this catalogue is performed by Zentiva only in those territories where it is permissible by applicable patent law; in particular, but not limited to Art. 10 EC Directive 2001/83. This catalogue shall not constitute an offer for sale of products and processes for the territories where an offer for sale or sale is not permissible by law. Zentiva expressly disclaims any liability for damages resulting from or arising out of the unauthorised use of such products and related processes.
Partner with us
At Zentiva, our growth is powered by strong, trusted partnerships. Together, we’re building the foundation for a more sustainable healthcare system, making a lasting, positive impact on the availability of medicines and on public health across Europe and beyond.